Selenium Treatment in Autoimmune Thyroiditis (AIT)

Status Completed

Clinical Trial Summary

Selenium suppresses autoimmune destruction of thyrocytes and decreases titers of serum TPOAb in AIT patients. Older 4 clinical trials approved the efficacy of the daily dose of 200micg. It's believed that Se saturates the deficient stores of GPX so GPX saves the thyrocytes against to oxidative stresses. Although less than 70 micg/d is sufficient to maximize GPX activity, none of the authors tested the doses less than 200 micg/d. Our hypothesis was that If 100 micg/d can not suppress the TPOAb titers,it means autoimmune destruction can not be blocked by saturation of deficient stores of GPX solely and the mechanism of action requires more than repletion of deficient stores. It's important not only to estimate the optimal dose but to understand the mechanism of action. High dose therapy may also suppress TPOAb levels in Se-non-deficient AIT patients, if it is so, Se therapy may becomes the solely treatment modality which can suppress the autoimmunity in more than 400 million AIT patients. Because there've been no way to suppress autoimmune war and replacement of LT4 had been the only treatment modality for palliation. An other independent part of the study is to test the effect of Se in adolescent AIT patients.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double-Blind, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00271427
Study type	Interventional
Source	Ege University
Contact
Status	Completed
Phase	N/A
Start date	December 2004
Completion date	August 2005

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT06249074` - Gluten-free Diet in Women With Autoimmune Thyroiditis	N/A
Completed	`NCT02240563` - Low Level Laser Therapy for Autoimmune Thyroiditis	N/A
Not yet recruiting	`NCT05544448` - In Vitro Effect Study of Interleukin-2 Muteins on Regulatory T Cells of Patients With Different Autoimmune, Allo-immune or Inflammatory Diseases	N/A
Completed	`NCT03289403` - The Role of Immunomodulatory Treatment in Success of ICSI in Patients With Autoimmune Thyroiditis	Phase 2
Completed	`NCT01129492` - Low-Level Laser Therapy in Chronic Autoimmune Thyroiditis	Phase 2
Completed	`NCT02013479` - Selenium Supplementation in Autoimmune Thyroiditis	N/A
Completed	`NCT03048708` - Thyroid in Bariatric Surgery	N/A
Completed	`NCT03498417` - Anti-insulin-like Growth Factor-1 Receptor (IGF-1R) Antibodies in Graves' Disease and Graves' Orbitopathy
Completed	`NCT02318160` - Oxidative Status in Children With Autoimmune Thyroiditis	N/A
Completed	`NCT05680376` - Thyroid Hormone Values and Anti-thyroid Peroxidase Antibody Positivity in Recurrent Pregnancy Loss
Completed	`NCT04754607` - Effects of Low-Level Laser Therapy on Oxidative Stress Levels...	N/A
Completed	`NCT04600349` - Identity Oriented Psychotrauma Therapy on Hashimoto in Adults	N/A
Completed	`NCT02644707` - Selenium Supplementation in Youths With Autoimmune Thyroiditis	Phase 4